Loading…
Lobbying Spend
—
Filings
50
Firms Hired
3
Active Period
2014–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
21st Century Cures Act
2016 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6
21st Century Cures Act
2016 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6
21st Century Cures Act
2016 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6
21st Century Cures Act
2016 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6
21st Century Cures Act
2015 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6
21st Century Cures Act
2015 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6
Source: Senate LDA